4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-090198
Chief Executive Officer acquired 42,826 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2025-06-25 | Grant or award | +42,826 | $4.67 | $199,997 | 268,566 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…